Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on eye contact and trust in a simulated patient-physician interaction
NL-OMON48289Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of oxytocin, sponsored by Amsterdam University Medical Center. Primary endpoints: Level of eye contact and Perceived relationship with the physician. Started Nov 2019; status: active, not recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NL-OMON48289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48289.